Parallels between immune driven-hematopoiesis and T cell activation: 3 signals that relay inflammatory stress to the bone marrow

Experimental Cell Research

Volumn 329, Issue 2, 2014, Pages 239-247

  Libregts, Sten F W M ^a,b   Nolte, Martijn A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Co stimulation; Cytokines; Hematopoiesis; HSC; Immune activation; TLRs

Indexed keywords

CYTOKINE; DAMAGE ASSOCIATED MOLECULAR PATTERN; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; NATURAL PRODUCTS AND THEIR SYNTHETIC DERIVATIVES; PATHOGEN ASSOCIATED MOLECULAR PATTERN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

BONE MARROW; CELL FUNCTION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEEDBACK SYSTEM; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; QUIESCENCE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; STRESS, PHYSIOLOGICAL; T-LYMPHOCYTES;

EID: 84922480697     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.09.016     Document Type: Review

References (76)

1. Ogawa M. Stochastic model revisited. Int. J. Hematol. 1999, 69:2-5.
2. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
3. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4:7-25.
4. Wang L.D., Wagers A.J. Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat. Rev. Mol. Cell Biol. 2011, 12:643-655.
5. Ding L., Morrison S.J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013, 495:231-235.
6. Greenbaum A., Hsu Y.M., Day R.B., Schuettpelz L.G., Christopher M.J., Borgerding J.N., Nagasawa T., Link D.C. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013, 495:227-230.
7. King K.Y., Goodell M.A. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 2011, 11:685-692.
8. Takizawa H., Boettcher S., Manz M.G. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 2012, 119:2991-3002.
9. Tokoyoda K., Zehentmeier S., Hegazy A.N., Albrecht I., Grun J.R., Lohning M., Radbruch A. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 2009, 30:721-730.
10. Feuerer M., Beckhove P., Garbi N., Mahnke Y., Limmer A., Hommel M., Hammerling G.J., Kyewski B., Hamann A., Umansky V., Schirrmacher V. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 2003, 9:1151-1157.
11. Cavanagh L.L., Bonasio R., Mazo I.B., Halin C., Cheng G., van der Velden A.W., Cariappa A., Chase C., Russell P., Starnbach M.N., Koni P.A., Pillai S., Weninger W., von Andrian U.H. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat. Immunol. 2005, 6:1029-1037.
12. Duffy D., Perrin H., Abadie V., Benhabiles N., Boissonnas A., Liard C., Descours B., Reboulleau D., Bonduelle O., Verrier B., van R.N., Combadiere C., Combadiere B. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells. Immunity 2012, 37:917-929.
13. Sapoznikov A., Pewzner-Jung Y., Kalchenko V., Krauthgamer R., Shachar I., Jung S. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat. Immunol. 2008, 9:388-395.
14. Schmid M.A., Takizawa H., Baumjohann D.R., Saito Y., Manz M.G. Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 2011, 118:4829-4840.
15. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
16. Takizawa H., Regoes R.R., Boddupalli C.S., Bonhoeffer S., Manz M.G. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J. Exp. Med. 2011, 208:273-284.
17. Esplin B.L., Shimazu T., Welner R.S., Garrett K.P., Nie L., Zhang Q., Humphrey M.B., Yang Q., Borghesi L.A., Kincade P.W. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J. Immunol. 2011, 186:5367-5375.
18. Nagai Y., Garrett K.P., Ohta S., Bahrun U., Kouro T., Akira S., Takatsu K., Kincade P.W. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006, 24:801-812.
19. Zhao J.L., Ma C., O'Connell R.M., Mehta A., DiLoreto R., Heath J.R., Baltimore D. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell 2014, 14:445-459.
20. Essers M.A., Offner S., Blanco-Bose W.E., Waibler Z., Kalinke U., Duchosal M.A., Trumpp A. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009, 458:904-908.
21. Frelin C., Herrington R., Janmohamed S., Barbara M., Tran G., Paige C.J., Benveniste P., Zuniga-Pflucker J.C., Souabni A., Busslinger M., Iscove N.N. GATA-3 regulates the self-renewal of long-term hematopoietic stem cells. Nat. Immunol. 2013, 14:1037-1044.
22. Sato T., Onai N., Yoshihara H., Arai F., Suda T., Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 2009, 15:696-700.
23. Welner R.S., Pelayo R., Nagai Y., Garrett K.P., Wuest T.R., Carr D.J., Borghesi L.A., Farrar M.A., Kincade P.W. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 2008, 112:3753-3761.
24. De Luca K., Frances-Duvert V., Asensio M.J., Ihsani R., Debien E., Taillardet M., Verhoeyen E., Bella C., Lantheaume S., Genestier L., Defrance T. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 2009, 23:2063-2074.
25. Sioud M., Floisand Y., Forfang L., Lund-Johansen F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J. Mol. Biol. 2006, 364:945-954.
26. Starczynowski D.T., Karsan A. Innate immune signaling in the myelodysplastic syndromes. Hematol./Oncol. Clin. N. Am. 2010, 24:343-359.
27. Khosravi A., Yanez A., Price J.G., Chow A., Merad M., Goodridge H.S., Mazmanian S.K. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014, 15:374-381.
28. Velegraki M., Koutala H., Tsatsanis C., Papadaki H.A. Increased levels of the high mobility group box 1 protein sustain the inflammatory bone marrow microenvironment in patients with chronic idiopathic neutropenia via activation of toll-like receptor 4. J. Clin. Immunol. 2012, 32:312-322.
29. Hofer M., Pospisil M., Weiterova L., Hoferova Z. The role of adenosine receptor agonists in regulation of hematopoiesis. Molecules 2011, 16:675-685.
30. 14 receptor modulates stress-induced hematopoietic stem/progenitor cell senescence. J. Clin. Investig. 2014, 124:3159-3171.
31. Wiesmann A., Phillips R.L., Mojica M., Pierce L.J., Searles A.E., Spangrude G.J., Lemischka I. Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity 2000, 12:193-199.
32. Nolte M.A., Arens R., van O.R., van O.M., Hooibrink B., van Lier R.A., van Oers M.H. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat. Immunol. 2005, 6:412-418.
33. Schurch C., Riether C., Matter M.S., Tzankov A., Ochsenbein A.F. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. J. Clin. Investig. 2012, 122:624-638.
34. De Colvenaer V., Taveirne S., Hamann J., de Bruin A.M., De S.M., Taghon T., Vandekerckhove B., Plum J., van L.R., Leclercq G. Continuous CD27 triggering in vivo strongly reduces NK cell numbers. Eur. J. Immunol. 2010, 40:1107-1117.
35. Lee S.W., Park Y., So T., Kwon B.S., Cheroutre H., Mittler R.S., Croft M. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat. Immunol. 2008, 9:917-926.
36. Jiang D., Chen Y., Schwarz H. CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages. J. Immunol. 2008, 181:3923-3932.
37. Tang Q., Jiang D., Alonso S., Pant A., Martinez Gomez J.M., Kemeny D.M., Chen L., Schwarz H. CD137 ligand signaling enhances myelopoiesis during infections. Eur. J. Immunol. 2013, 43:1555-1567.
38. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 2001, 58:4-43.
39. Seijkens T., Engel D., Tjwa M., Lutgens E. The role of CD154 in haematopoietic development. Thromb. Haemost. 2010, 104:693-701.
40. Flores-Romo L., Bjorck P., Duvert V., van K.C., Saeland S., Banchereau J. CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 1997, 185:341-349.
41. Solanilla A., Dechanet J., El A.A., Dupouy M., Godard F., Chabrol J., Charbord P., Reiffers J., Nurden A.T., Weksler B., Moreau J.F., Ripoche J. CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells. Blood 2000, 95:3758-3764.
42. Mavroudi I., Papadaki H.A. The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis. Sci. World J. 2011, 11:2011-2019.
43. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002, 21:3295-3313.
44. Bryder D., Ramsfjell V., Dybedal I., Theilgaard-Monch K., Hogerkorp C.M., Adolfsson J., Borge O.J., Jacobsen S.E. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J. Exp. Med. 2001, 194:941-952.
45. Jacobsen F.W., Rothe M., Rusten L., Goeddel D.V., Smeland E.B., Veiby O.P., Slordal L., Jacobsen S.E. Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis. Proc. Natl. Acad. Sci. USA 1994, 91:10695-10699.
46. Zhang Y., Harada A., Bluethmann H., Wang J.B., Nakao S., Mukaida N., Matsushima K. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995, 86:2930-2937.
47. Selleri C., Sato T., Anderson S., Young N.S., Maciejewski J.P. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J. Cell. Physiol. 1995, 165:538-546.
48. Pronk C.J., Veiby O.P., Bryder D., Jacobsen S.E. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J. Exp. Med. 2011, 208:1563-1570.
49. Rusten L.S., Jacobsen S.E. Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood 1995, 85:989-996.
50. Stifter G., Heiss S., Gastl G., Tzankov A., Stauder R. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Eur. J. Haematol. 2005, 75:485-491.
51. Hara T., Ando K., Tsurumi H., Moriwaki H. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur. J. Haematol. 2004, 73:10-16.
52. Mundle S.D., Ali A., Cartlidge J.D., Reza S., Alvi S., Showel M.M., Mativi B.Y., Shetty V.T., Venugopal P., Gregory S.A., Raza A. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes. Am. J. Hematol. 1999, 60:36-47.
53. Broxmeyer H.E., Lu L., Platzer E., Feit C., Juliano L., Rubin B.Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 1983, 131:1300-1305.
54. Binder D., Fehr J., Hengartner H., Zinkernagel R.M. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 1997, 185:517-530.
55. Pietras E.M., Lakshminarasimhan R., Techner J.M., Fong S., Flach J., Binnewies M., Passegue E. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J. Exp. Med. 2014, 211:245-262.
56. Snoeck H.W., Van Bockstaele D.R., Nys G., Lenjou M., Lardon F., Haenen L., Rodrigus I., Peetermans M.E., Berneman Z.N. Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells. J. Exp. Med. 1994, 180:1177-1182.
57. Yang L., Dybedal I., Bryder D., Nilsson L., Sitnicka E., Sasaki Y., Jacobsen S.E. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J. Immunol. 2005, 174:752-757.
58. de Bruin A.M., Demirel O., Hooibrink B., Brandts C.H., Nolte M.A. Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood 2013, 121:3578-3585.
59. Baldridge M.T., King K.Y., Boles N.C., Weksberg D.C., Goodell M.A. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010, 465:793-797.
60. Weiss G., Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352:1011-1023.
61. Libregts S.F., Gutiérrez L., de Bruin A.M., Wensveen F., Papadopoulos P., van IJcken W., Özgür Z., Philipsen S., Nolte M.A. Chronic IFNγ production in mice induces anemia by reducing erythrocyte lifespan and inhibiting erythropoiesis through an IRF-1/PU.1-axis. Blood 2011, 118:2578-2588.
62. Rekhtman N., Radparvar F., Evans T., Skoultchi A.I. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999, 13:1398-1411.
63. Millot S., Andrieu V., Letteron P., Lyoumi S., Hurtado-Nedelec M., Karim Z., Thibaudeau O., Bennada S., Charrier J.L., Lasocki S., Beaumont C. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood 2010, 116:6072-6081.
64. de Bruin A.M., Libregts S.F., Valkhof M., Boon L., Touw I.P., Nolte M.A. IFNgamma induces monopoiesis and inhibits neutrophil development during inflammation. Blood 2012, 119:1543-1554.
65. de Bruin A.M., Buitenhuis M., van der Sluijs K.F., van Gisbergen K.P., Boon L., Nolte M.A. Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. Blood 2010, 116:2559-2569.
66. Young H.A., Klinman D.M., Reynolds D.A., Grzegorzewski K.J., Nii A., Ward J.M., Winkler-Pickett R.T., Ortaldo J.R., Kenny J.J., Komschlies K.L. Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood 1997, 89:583-595.
67. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., Krimpenfort P., Borst J., van Oers M.H., van Lier R.A. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001, 15:801-812.
68. Corfe S.A., Rottapel R., Paige C.J. Modulation of IL-7 thresholds by SOCS proteins in developing B lineage cells. J. Immunol. 2011, 187:3499-3510.
69. de Bruin A.M., Voermans C., Nolte M.A. Impact of interferon-gamma on hematopoiesis. Blood 2014, (e-pub ahead of print). 10.1182/blood-2014-04-568451.
70. Ueda Y., Cain D.W., Kuraoka M., Kondo M., Kelsoe G. IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol. 2009, 182:6477-6484.
71. Krstic A., Mojsilovic S., Jovcic G., Bugarski D. The potential of interleukin-17 to mediate hematopoietic response. Immunol. Res. 2012, 52:34-41.
72. Di Rosa F., Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 2005, 26:360-366.
73. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I.R., Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007, 109:1422-1432.
74. Tomchuck S.L., Zwezdaryk K.J., Coffelt S.B., Waterman R.S., Danka E.S., Scandurro A.B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008, 26:99-107.
75. Shi C., Jia T., Mendez-Ferrer S., Hohl T.M., Serbina N.V., Lipuma L., Leiner I., Li M.O., Frenette P.S., Pamer E.G. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011, 34:590-601.
76. Schurch C.M., Riether C., Ochsenbein A.F. Cytotoxic CD8 T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell 2014, 14:460-472.